CD44 and breast carcinoma: To determine if WISP2/CCN5 knock-down also promotes a tumor stem-like cell phenotype, flow cytometry analysis was used to sort cells based on the expression of CD44 and CD24, two cell surface markers whose expression in the CD44high/CD24low configuration has been associated with breast cancer stem cells [26].